Navigation Links
Sigma-Tau Pharmaceuticals, Inc. Announces Addition of VP of Finance
Date:7/1/2011

GAITHERSBURG, Md., July 1, 2011 /PRNewswire/ -- Sigma-Tau Pharmaceuticals, Inc. announced the appointment of Dave Lemus as its new vice president of finance, effective July 1, 2011.  Lemus will join the leadership team at Sigma-Tau Pharmaceuticals U.S. corporate headquarters in Gaithersburg, Md.

For the past 13 years, Lemus served as chief financial officer of MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX), one of the Europe's leading biotechnology companies focused on fully human antibodies.  In this position, he held responsibilities for a variety of areas, including corporate development, technical operations, corporate legal, human resources, and public and investor relations.  In 1999, Lemus led the effort to take the company public, successfully completing Germany's first-ever biotech initial public offering.  For the next decade thereafter, he played a central role in helping grow the company into one of Europe's leading life science companies.

"I'm very pleased to become part of the Sigma-Tau growth story going forward as its new vice president of finance," commented Lemus.  "Moreover, Sigma-Tau's considerable expertise in rare diseases will continue to play a decisive role in propelling the company's high rate of growth and expansion over the coming years."

Prior to his role at MorphoSys AG, Lemus was a controller and operations manager at Hoffmann-La Roche, and preceding this position, he served as the treasurer of the Lindt Chocolate Company.

"As a leader in the development and commercialization of medicines for rare diseases, we have undergone tremendous growth in the past few years," said Gregg Lapointe, CEO, Sigma-Tau Pharmaceuticals, Inc.  "In looking to the future, it's imperative we have talented people like Dave to help Sigma-Tau continue to bring innovation to the field of rare diseases.  We're very pleased to welcome him to the team."

Sigma-Tau Pharmaceuticals, In
'/>"/>

SOURCE Sigma-Tau Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
2. Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
7. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
8. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 1, 2014   Intarcia Therapeutics, Inc. today ... phase 3 clinical trials for ITCA 650 (exenatide, delivered ... osmotic mini-pump). The first trial, FREEDOM-1, was a placebo-controlled, ... and safety of ITCA 650 in patients with type ... to be significantly superior to placebo for both 40 ...
(Date:10/1/2014)... and NOTTINGHAM, England , Oct. ... CBRX ) today announced that its subsidiary, Molecular Profiles ... Trials platform at the annual CPhI/ICSE Worldwide event in ... to support companies with the rapid development of both ... enabling technologies screening platform, which incorporates the company,s existing ...
(Date:10/1/2014)... Oct. 1, 2014  Varian Medical Systems (NYSE: ... results for the fourth quarter of fiscal year 2014 ... 22, 2014.  The news release will be followed by ... p.m. PT.  The news release and a link to ... company website at: www.varian.com/investor .  To access the ...
Breaking Medicine Technology:Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 2Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 5Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2
... FLEX ) is expanding its medical disposables offering ... through a share purchase agreement. Slomedical is a leading ... sets to complex devices for minimally-invasive surgery. This deal ... calendar year, pending required regulatory clearances. , Upon ...
... , CLINTON, N.J., Oct. 21 Ikaria Holdings, Inc. ... Award for Excellence in Business Expansion by the New ... employer association in the United States. Ikaria earned ... revenues, as well as the net creation of new ...
Cached Medicine Technology:Flextronics Announces Expansion of Medical Disposables Offering 2Ikaria Receives Award for Excellence by New Jersey Business & Industry Association 2
(Date:10/2/2014)... 2014 Recently, BambooIndustry.com, a professional company ... collection of bamboo floors . What’s more, the ... of its products at the moment. According to the ... 26 percent off. The promotion will be valid until ... http://www.bambooindustry.com ) are all made by qualified workers. A ...
(Date:10/2/2014)... BamboofloorChina.com is a distinguished bamboo product manufacturer ... appreciation from the global customers in the past few ... more excellent items. All its online workers are professional ... , The company has recently added a new ... Furthermore, the company’s marketing specialist has announced that all ...
(Date:10/2/2014)... Children with autism are more sedentary than those without ... active, a small study suggests. Researchers tested the ... autism and some without. Children with autism averaged 50 ... 70 more minutes each day sitting than those without ... on strength, but had similar body-mass index (a measurement ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... the District of Columbia now have a total of 500 ... has been infecting children since the summer, U.S. health ... have died in recent weeks, but it,s not clear what ... deaths, officials said. Health officials are also trying to ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com: Great Bamboo Floors At Discounted Rates 2Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3Health News:Study finds acupuncture does not improve chronic knee pain 2
... method cuts death risk, study finds , WEDNESDAY, Aug. ... who receive early non-invasive ventilation after a breathing tube ... failure or die, a Spanish study has found. , ... of them had high levels of carbon dioxide in ...
... behind progress, study finds , THURSDAY, Aug. 13 (HealthDay ... younger people, new research shows. , And while cancer ... the United States, topping heart disease, that is because ... cancer. , "Older Americans have only experienced decreased [cancer] ...
... YORK, Aug. 13 The International Longevity Center, with support ... $20,000 grants for caregiver training programs. , , ... Initiative grants are part of the Caregiving Project for ... the Schmieding Center for Senior Health and Education. The initiative ...
... , , BALTIMORE, Aug. ... Maryland, the Black Nurses Association of Baltimore and the Greater ... Health Insurer Code of Conduct from the American Medical Association. ... portion of the state,s racial and ethnic minorities, including African ...
... , THOUSAND OAKS, Calif., Aug. 13 ... data from the submitted Biologic License Applications (BLAs) for denosumab for ... treatment of bone loss in breast and prostate cancer patients undergoing ... Administration,s (FDA) Advisory Committee for Reproductive Health Drugs (ACRHD). , ...
... RICHMOND, Va., Aug. 13 Insmed Inc. (Nasdaq: ... second quarter and six-months ended June 30, 2009. , , ... were $3.0 million, up from $2.7 million for the corresponding period ... grant revenue related to the IPLEX(TM) myotonic muscular dystrophy ("MMD") clinical ...
Cached Medicine News:Health News:Ventilation After Breathing Tube Removal May Alter Outcomes 2Health News:Cancer Deaths Declining, Especially Among Young 2Health News:Cancer Deaths Declining, Especially Among Young 3Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 2Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 3Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 4Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 5Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 2Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 2Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 4Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 5Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 6Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 7Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 2Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 3Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 4Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 5Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 6Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 7Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 8Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 9
.90mm (20G) guillotine cutting probe with 1.4mm (17G) removable irrigation sleeve...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
...
Designed for stab incisions...
Medicine Products: